Goldman Sachs

Goldman Sachs gives managers a choice: Dallas, Salt Lake City or leave

The bank is trying to send more managers to locales outside its main hubs in an initiative dubbed informally by some as 'Project Voyage'

Goldman Sachs Asset exits Sterlite Tech, sells 2.13% stake for Rs 84 crore

Goldman Sachs Asset Management on Wednesday divested a little over 2 per cent stake in Anil Agarwal promoted-Sterlite Technologies for Rs 84 crore through an open market transaction. Goldman Sachs Asset Management through its affiliate Goldman Sachs Funds - Goldman Sachs India Equity Portfolio sold 1.03 crore shares, amounting to a 2.13 per cent stake in Sterlite Technologies, according to BSE data. The shares were offloaded at an average price of Rs 81.04 apiece, taking the deal value to Rs 84.10 crore. Meanwhile, Bandhan Mutual Fund bought 60.11 lakh shares or 1.23 per cent stake in Sterlite Technologies for Rs 48.69 crore. The shares were acquired at an average price of Rs 81 apiece. Details of the other buyers of Sterlite Technologies' shares could not be ascertained on the BSE. The stock of Sterlite Technologies fall 4.02 per cent to close at Rs 80.29 apiece on the BSE.

Trump tariffs meant to 'level the playing field', says Goldman Sachs CEO

Trump said on Monday he will impose a 25 per cent tariff on goods imported from Canada and Mexico, effective from today

Goldman Sachs exits ISGEC Heavy Engineering, sells shares for Rs 96 crore

Global investment banking major Goldman Sachs on Thursday exited ISGEC Heavy Engineering, by selling its 1.4 per cent stake in the company for Rs 96 crore through an open market transaction. US-based Goldman Sachs through its arm Goldman Sachs Funds -- Goldman Sachs India Equity Portfolio sold 10.43 lakh shares, or 1.42 per cent stake, in ISGEC Heavy Engineering, as per the bulk deal data available on the National Stock Exchange (NSE). The shares were offloaded at an average price of Rs 915.49 apiece, taking the transaction value to Rs 95.50 crore. Meanwhile, Nippon India Mutual Fund acquired 8.32 lakh shares, or 1.13 per cent stake, in Noida-based ISGEC Heavy Engineering. The shares were picked up at an average price of Rs 915 apiece, taking the transaction size to Rs 76.21 crore. Details of the other buyers of ISGEC Heavy Engineering's shares could not be ascertained. On Wednesday, shares of ISGEC Heavy Engineering slipped 1.37 per cent to close at Rs 938 per piece on the NSE.

US tariff hike may hit India's GDP growth by up to 0.6 pp: Goldman Sachs

This forecast considers various scenarios, including the US government's planned reciprocal tariffs in early April and the price elasticity of US demand for Indian exports

Goldman Sachs acquires BSE shares worth Rs 401 cr via market deal

Banking and financial services major Goldman Sachs on Wednesday bought shares of leading stock exchange BSE for Rs 401 crore through an open market transaction. According to the bulk deal data available on National Stock Exchange (NSE), US-based Goldman Sachs through its arm Goldman Sachs (Singapore) purchased 7.28 lakh shares of BSE Ltd. The shares of Mumbai-headquartered BSE were picked up at an average price of Rs 5,504.42 apiece, taking the deal value to Rs 401.19 crore. Details of the sellers of BSE shares could not be ascertained on the bourse. Shares of BSE rallied 8.14 per cent to close at Rs 5,608.50 per piece on the NSE on Wednesday. On February 6, BSE reported its net profit doubling to Rs 220 crore for three months ended December 2024. The company had posted a net profit of Rs 108.2 crore in the same quarter of preceding fiscal. The exchange recorded its highest-ever quarterly revenue of Rs 835.4 crore in October-December period of current financial year (FY25), a 94

Don't see Ukraine ceasefire boosting Russia's output, says Goldman Sachs

US President Donald Trump's administration said it had agreed to hold more talks with Russia on ending the war in Ukraine

GenAI to become immersive across our businesses: Goldman Sachs' Samtani

Samtani talks about Indian engineers and Generative AI (GenAI) in banking

Goldman Sachs sees Trump immigration moves shaving US economic growth

The analysts see net immigration to the US plummeting to 750,000 a year, shaving 30-40 basis points (0.3-0.4 percentage points) off potential gross domestic product growth this year

Weak demand weighs on Asian Paints Q3; analysts see more pain in near-term

Asian Paints' consolidated net profit attributable to the owners of the company declined 23.3 per cent year-on-year (Y-o-Y) to Rs 1,110.5 crore in Q3FY25, down from Rs 1,447.7 crore in Q3FY24

Trump's tariffs to have limited impact on oil, gas prices: Goldman Sachs

Potential tariff-driven decline in US natural gas imports from Canada is too small to significantly raise US natural gas prices, the bank said

President Putin allows Goldman Sachs to sell its business in Russia

Putin permitted Balchug Capital to buy the division, according to a decree he signed

Tata Consumer share up 5% despite muted Q3; tea inflation worries analysts

Analysts observed that Tata Consumer Products faced margin pressures primarily due to inflationary tea prices but continued to post robust volume growth across its beverage and food segments

Tata Motors Q3 disappoints, analysts lower targets, ratings; stock tanks 9%

Tata Motors' consolidated profit for Q3FY25 fell 22.4 per cent year-on-year (Y-o-Y) to Rs 5,451 crore, from Rs 7,025 crore in Q3FY24

Most brokerages lift targets for UltraTech Cement as Q3 nos. top estimates

Goldman Sachs reportedly has maintained a 'Buy' rating and increased its target price to Rs 12,580, up from Rs 12,460, citing volume recovery and lower costs contributing to margin improvement

Goldman boosts CEO pay by 26% to $39 mn, lines up five more years at helm

The latest bonuses are an effort by Goldman's board to retain the CEO and COO as a senior leadership team, the company said in the filing

CCI fines Goldman Sachs manager Rs 40 lakh over Biocon deal failure

The Competition Commission has imposed a penalty of Rs 40 lakh on the investment manager of Goldman Sachs AIF for failing to notify the regulator about the more than four-year-old deal that gives the option to buy up to 3.81 per cent stake in Biocon Biologics. The penalty was levied on Goldman Sachs (India) Alternative Investment Management Pvt Ltd (GS AIMPL), the investment manager of Goldman Sachs AIF, for a contravention of Section 6(2) of the Competition Act, which mandates prior approval for certain combinations. Under the deal, Goldman Sachs AIF Scheme-1 (GS AIF) had acquired optionally convertible debentures (OCDs) issued by Biocon Biologics. The regulator has penalised GS AIMPL for failing to notify the transaction to it and rejected the argument that the deal was done in the ordinary course of business. "Any transaction which is made with the intent of remaining invested for a relatively longer period and involves the acquisition of any additional rights (compared to the .

Goldman Sachs profit surges as investment banking, trading fuel Q4 growth

Profit rose to $4.11 billion, or $11.95 per diluted share, for the three months ended Dec. 31, compared with $2.01 billion, or $5.48 per diluted share, a year ago

Budget FY26: Goldman Sachs highlights focus on fiscal deficit, growth

India's elevated public debt-to-GDP ratio remains a concern. A reduction in the general fiscal deficit from 8 per cent in FY25 to 7 per cent by FY30 is critical to keeping public debt sustainable

Aragen secures $100 mn funding from Quadria Capital, plans expansion

Contract research, development and manufacturing organisation Aragen on Monday said it has secured USD 100 million investment from private equity fund Quadria Capital. The investment will result in Quadria acquiring a minority stake in Aragen, at a valuation of around USD 1.4 billion, primarily through a fresh capital infusion, with a small portion from the sale of shares by existing investors, the company said in a statement. The funding will support the company's strategic expansion of its capabilities and infrastructure, enabling it to meet the growing demand for outsourcing services from innovators in the US and Europe, it added. With investment, Quadria joins Goldman Sachs as the second strategic investor in Aragen. "This investment marks a pivotal moment as we scale to meet the needs of a rapidly evolving market, said Manni Kantipudi, CEO, Aragen Life Science. "Our expanded capabilities will allow us to support the rising demand for integrated discovery and manufacturing ...